Literature DB >> 22465095

Influence of bile on the absorption of halofantrine from lipid-based formulations.

René Holm1, Henrik Tønsberg, Erling B Jørgensen, Puyan Abedinpour, Shafiq Farsad, Anette Müllertz.   

Abstract

The bioavailability of the poorly soluble model drug halofantrine, dosed in a soy bean oil solution or in a self-nanoemulsifying drug delivery system (SNEDDS), at two levels of lipid, was assessed in rats. Three rat models were used: intact rats, sham-operated rats and bile duct cannulated rats. The study showed no difference in the pharmacokinetic parameters between intact and sham-operated rats. T(max) increased with lipid load for both oil solution and SNEDDS, whereas C(max) and the absolute bioavailability were significantly higher for the SNEDDS at both lipid dosing levels. Bile duct cannulation of the rats reduced the C(max) and the absolute bioavailability of halofantrine significantly, by a factor of 2, for all 4 treatments. These data clearly demonstrate that bile has an importance for the absorption of drugs from lipid-based formulations independent of the type.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22465095     DOI: 10.1016/j.ejpb.2012.03.005

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  7 in total

1.  Bioavailability of cinnarizine in dogs: effect of SNEDDS loading level and correlation with cinnarizine solubilization during in vitro lipolysis.

Authors:  Anne T Larsen; Pernilla Åkesson; Anna Juréus; Lasse Saaby; Ragheb Abu-Rmaileh; Bertil Abrahamsson; Jesper Østergaard; Anette Müllertz
Journal:  Pharm Res       Date:  2013-08-15       Impact factor: 4.200

2.  Consideration of the efficacy of non-ionic vesicles in the targeted delivery of oral vaccines.

Authors:  Jitinder S Wilkhu; Sarah E McNeil; David E Anderson; Yvonne Perrie
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

3.  First-in-humans study of the safety, tolerability, and pharmacokinetics of ACT-451840, a new chemical entity with antimalarial activity.

Authors:  Shirin Bruderer; Noémie Hurst; Ruben de Kanter; Tommaso Miraval; Thomas Pfeifer; Yves Donazzolo; Jasper Dingemanse
Journal:  Antimicrob Agents Chemother       Date:  2014-11-24       Impact factor: 5.191

4.  Self-nanoemulsifying drug delivery systems ameliorate the oral delivery of silymarin in rats with Roux-en-Y gastric bypass surgery.

Authors:  Chun-Han Chen; Cheng-Chih Chang; Tsung-Hsien Shih; Ibrahim A Aljuffali; Ta-Sen Yeh; Jia-You Fang
Journal:  Int J Nanomedicine       Date:  2015-03-25

Review 5.  Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.

Authors:  Arshad Ali Khan; Jahanzeb Mudassir; Noratiqah Mohtar; Yusrida Darwis
Journal:  Int J Nanomedicine       Date:  2013-07-26

6.  SNEDDS Containing Poorly Water Soluble Cinnarizine; Development and in Vitro Characterization of Dispersion, Digestion and Solubilization.

Authors:  Anne T Larsen; Anayo Ogbonna; Ragheb Abu-Rmaileh; Bertil Abrahamsson; Jesper Ostergaard; Anette Müllertz
Journal:  Pharmaceutics       Date:  2012-12-14       Impact factor: 6.321

7.  Development, Statistical Optimization and Characterization of Fluvastatin Loaded Solid Lipid Nanoparticles: A 32 Factorial Design Approach.

Authors:  Afzal Haq Asif; Prasanna Kumar Desu; Rajasekhar Reddy Alavala; Gudhanti Siva Naga Koteswara Rao; Nagaraja Sreeharsha; Girish Meravanige
Journal:  Pharmaceutics       Date:  2022-03-08       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.